Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
1.240
-0.100 (-7.46%)
At close: Apr 17, 2026, 4:00 PM EDT
1.280
+0.040 (3.19%)
After-hours: Apr 17, 2026, 7:31 PM EDT
Tiziana Life Sciences Market Cap
Tiziana Life Sciences has a market cap or net worth of $158.25 million as of April 17, 2026. Its market cap has increased by 30.70% in one year.
Market Cap
158.25M
Enterprise Value
151.11M
1-Year Change
30.70%
Ranking
Category
Stock Price
$1.24
Market Cap Chart
Since October 21, 2021, Tiziana Life Sciences's market cap has increased from $145.96M to $158.25M, an increase of 8.42%. That is a compound annual growth rate of 1.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 158.25M | -10.62% |
| Dec 31, 2025 | 177.05M | 133.12% |
| Dec 31, 2024 | 75.95M | 34.82% |
| Dec 29, 2023 | 56.33M | -7.14% |
| Dec 30, 2022 | 60.66M | -35.06% |
| Dec 31, 2021 | 93.41M | -36.00% |
| Oct 21, 2021 | 145.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protalix BioTherapeutics | 185.31M |
| Replimune Group | 180.83M |
| Corbus Pharmaceuticals Holdings | 179.85M |
| Agenus | 178.17M |
| Heron Therapeutics | 177.22M |
| Unicycive Therapeutics | 174.14M |
| Cartesian Therapeutics | 169.13M |
| Connect Biopharma Holdings | 169.00M |